Genedata Expands Biomarker Discovery Collaboration with Syngenta for Improving Metabolomic Data Processing
News Feb 26, 2009
Genedata has announced the extension of a biomarker discovery collaboration with Syngenta. Syngenta has added the Genedata Expressionist Refiner MS module for LC-MS and GC-MS metabolomic raw data processing and analysis to their existing Genedata Expressionist system.
Refiner MS expands Expressionist to process and analyze metabolomic raw MS data separately and in conjunction with microarray data, improving efficiency and enhancing the biomarker discovery process at Syngenta.
Syngenta has been successfully using the Genedata Expressionist Refiner Array and Analyst modules to process and analyze microarray data since 2005. With the rapid expansion of metabolomics research and the associated data volumes generated, Syngenta now uses Refiner MS to integrate MS data in their biomarker discovery projects.
With Refiner MS Syngenta can process rapidly and with full confidence in quality extremely large amounts of MS data directly from multiple hardware platforms via user defined, flexible workflows. Peaks selection is performed automatically in Refiner MS while statistical analysis and biological pathway mapping are done in the analytical module Analyst.
Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.READ MORE
Scientists report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP). The strategy could one day be used to slow or prevent vision loss in people with the disease. NEI is part of the National Institutes of Health.